跳至主要内容
临床试验/NCT07630896
NCT07630896招募中4 期

Postoperative Prednisone Regimen in TKA and Its Effect on Continuous Glucose Levels

Columbia University2 个研究点 分布在 1 个国家目标入组 104 人开始时间: 2026年6月22日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
104
试验地点
2
主要终点
Pain at Rest

研究概览

简要总结

This study compares the efficacy of a 5-day post-operative oral prednisone regimen (40 mg daily) with the standard intraoperative steroid regimen, focusing on pain, swelling, range of motion, opioid use, and glucose levels monitored continuously.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Undergoing Primary Unicompartmental Knee Arthroplasty or Total Hip Arthroplasty
  • •Age 18 and above

排除标准

  • •Steroid therapy
  • •Narcotic use within past 3 months
  • •History of corticosteroid intolerance
  • •Pregnancy
  • •Uncontrolled diabetes
  • •Doesn't own smart phone
  • •Drop Criteria:
  • •- 2nd dose of IV dexamethasone

研究组 & 干预措施

Post-operative Steroids

Active Comparator

Participants will receive a 5-day regimen of 40 mg oral prednisone postoperatively.

干预措施: Prednisone (Drug)

Post-operative Steroids

Active Comparator

Participants will receive a 5-day regimen of 40 mg oral prednisone postoperatively.

干预措施: Continuous Glucose Monitor (Device)

Post-operative Steroids

Active Comparator

Participants will receive a 5-day regimen of 40 mg oral prednisone postoperatively.

干预措施: InkWell Health Tattoos (Other)

Standard of care

Placebo Comparator

Participants will receive standard of care treatment, consisting of the intravenous administration of dexamethasone and periarticular administration of steroids intraoperatively.

干预措施: Continuous Glucose Monitor (Device)

Standard of care

Placebo Comparator

Participants will receive standard of care treatment, consisting of the intravenous administration of dexamethasone and periarticular administration of steroids intraoperatively.

干预措施: InkWell Health Tattoos (Other)

结局指标

主要结局

Pain at Rest

时间窗: 2 weeks

Pain intensity at rest will be measured using the 11-point Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain). The NRS is a validated and standardized tool for assessing patient-reported pain.

Pain with Ambulation

时间窗: 2 weeks

Pain intensity with ambulation will be measured using the 11-point Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain). The NRS is a validated and standardized tool for assessing patient-reported pain.

次要结局

  • Continuous Glucose Levels(2 weeks)
  • Adverse Outcomes(2 weeks)
  • Swelling(2 weeks)
  • Range of Motion(2 weeks)
  • Opioid Consumption(2 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Roshan P. Shah

Russell A. Hibbs Associate Professor of Orthopedics in Orthopedic Surgery and in Surgery

Columbia University

研究点 (2)

Loading locations...

相似试验